tiprankstipranks
Advertisement
Advertisement

Waterdrop Posts Surging 2025 Q4 Growth and Announces New Cash Dividend

Story Highlights
  • Waterdrop’s Q4 2025 revenue and profits surged on strong insurance-related income and AI-driven efficiency gains across its core operations.
  • The company strengthened crowdfunding risk controls, expanded digital clinical trial partnerships, and boosted shareholder returns via buybacks and a new dividend.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Waterdrop Posts Surging 2025 Q4 Growth and Announces New Cash Dividend

Claim 55% Off TipRanks

Waterdrop ( (WDH) ) just unveiled an update.

Waterdrop Inc. reported unaudited results for the fourth quarter and full year 2025 on March 25, 2026, highlighting a sharp acceleration in growth and profitability driven by its AI-led strategy. Net operating revenue in the fourth quarter surged 105.5% year over year to RMB1.41 billion, with insurance-related income jumping 125.0% and digital clinical trial revenue rising 39.9%, while operating profit climbed 58.4% to RMB83.9 million and net profit attributable to ordinary shareholders rose 62.7% to RMB162.1 million.

Management said AI deployment across core insurance operations boosted scalability and efficiency, citing rapid growth in premiums facilitated by its “AI Medical Insurance Expert” and heavy use of its AI customer service and quality assurance tools. The company also reinforced risk controls in its medical crowdfunding business and secured a national invention patent for an intelligent drug‑patient matching system that underpinned expanded collaborations with 224 pharma and contract research partners.

By December 31, 2025, Waterdrop’s platforms had enabled RMB72.3 billion in donations to 3.68 million patients and enrolled 14,555 patients into 1,611 clinical trial programs, underscoring its scale in patient support and clinical enrollment. In parallel, Waterdrop continued capital returns to investors, disclosing that by the end of February 2026 it had repurchased about 60.7 million ADSs for roughly US$118.1 million and that its board had approved a new cash dividend of approximately US$10.8 million.

The most recent analyst rating on (WDH) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Waterdrop stock, see the WDH Stock Forecast page.

Spark’s Take on WDH Stock

According to Spark, TipRanks’ AI Analyst, WDH is a Outperform.

The score is driven primarily by improved profitability and a very strong, low-leverage balance sheet, supported by an attractive valuation (low P/E and a ~2.1% dividend yield). These positives are tempered by the key risk of weak cash generation in 2024 (zero operating/free cash flow) and only moderately positive technical momentum.

To see Spark’s full report on WDH stock, click here.

More about Waterdrop

Waterdrop Inc., listed on the NYSE under the ticker WDH, operates as a technology platform focused on insurance and healthcare services in China. The company’s core businesses span insurance brokerage and related technical services, a large-scale medical crowdfunding platform, and digital clinical trial solutions that match patients with pharmaceutical and biotech-sponsored studies.

Average Trading Volume: 287,697

Technical Sentiment Signal: Hold

Current Market Cap: $593.1M

See more insights into WDH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1